Non-anesthetist-administered moderate sedation with midazolam and fentanyl for outpatient MRI-aided hybrid intracavitary and interstitial brachytherapy in cervix cancer: a single-institution experience.
Non-anesthetist-administered moderate sedation with midazolam and fentanyl for outpatient MRI-aided hybrid intracavitary and interstitial brachytherapy in cervix cancer: a single-institution experience.
复制标题
DOI:
10.5114/jcb.2021.105946
复制
发表时间:
2021-06
影响因子:
1.4
通讯作者:
Tan TK
中科院分区:
文献类型:
--
作者:
Sommat K;Lin JYX;Chew MML;Loh CS;Liew JSK;Foo YW;Kwek JW;Hennedige T;Goh JPS;Tan TK
The aim of the study was to determine the feasibility of interstitial brachytherapy under non-anesthetist-administered moderate sedation, to identify factors influencing the insertion, and the total procedural time. A total of 47 insertions with hybrid intracavitary and interstitial applicators were performed in 23 patients from March 2017 to March 2020. Moderate sedation was achieved with intravenous midazolam and fentanyl administered by non-anesthetist. Insertion time and procedural time was recorded. Univariate and multivariate analysis were performed to evaluate the impact of different factors on insertion and procedural time. A total of 238 needles (range, 2-8 per insertion) were implanted, with an average insertion depth of 30 mm (range, 20-40 mm). The mean doses for midazolam and fentanyl were 3 mg (standard deviation [SD] = 1) and 53.3 mcg (SD = 23.9) per insertion, respectively. The median insertion time was 30 minutes (interquartile range [IQR] = 22-40), and the median total procedural time was 4.3 hours (IQR = 3.6-5.2). First time insertion, insertions performed before 2019, and higher midazolam dose were associated with significantly longer insertion time, whereas longer insertion time, MRI-based planning, and insertions performed before 2019 were associated with significantly longer total procedural time. Outpatient interstitial brachytherapy with non-anesthetist-administered sedation is achievable and well-tolerated. This method may significantly lessen the burden on hospital resources and has the potential to be cost-effective.
登录
查看更多内容
影响因子:
2.6
作者:
Bhanabhai, H.;Samant, R.;Lowry, S.
通讯作者:
Lowry, S.
影响因子:
7.7
作者:
Mamula, Petar;Markowitz, Jonathan E.;Liacouras, Chris A.
通讯作者:
Liacouras, Chris A.
影响因子:
2
作者:
Ohno T;Wakatsuki M;Toita T;Kaneyasu Y;Yoshida K;Kato S;Ii N;Tokumaru S;Ikushima H;Uno T;Noda SE;Kazumoto T;Harima Y;The Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG)
通讯作者:
The Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG)
DOI:
10.1097/igc.0000000000000929
发表时间:
2017-05
期刊:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
影响因子:
--
作者:
Liu ZS;Guo J;Zhao YZ;Lin X;Zhang BY;Zhang C;Wang HY;Yu L;Ren XJ;Wang TJ
通讯作者:
Wang TJ
影响因子:
1.9
作者:
Khader, Ruba;Oreadi, Daniel;Rosenberg, Morton
通讯作者:
Rosenberg, Morton